Piramal Healthcare isn't up for sale
company announced that Piramal Healthcare isn't up for sale but market
rumers have taken stock up 20% today
so will this company go like ranbaxy as first denial and then final sale?
Piramal Healthcare isn't up for sale
company announced that Piramal Healthcare isn't up for sale but market
rumers have taken stock up 20% today
so will this company go like ranbaxy as first denial and then final sale?
HERE IS AJAY PIRAMAL Press release -
"We are doing everything to improve the business," Piramal told Dow Jones Newswires. "We are taking steps to grow organically. We are taking steps to grow inorganically as well."
Piramal Healthcare isn't up for sale and the company hasn't had any talks with potential buyers, he said.
Friday, The Wall Street Journal reported U.K.-based drug giant GlaxoSmithKline PLC (GSK) is in talks to buy Piramal Healthcare for roughly $1.5 billion, citing people familiar with the matter.
Other drug companies have also shown an interest in Piramal Healthcare, including France's Sanofi-Aventis (SNY), the report said.
Piramal Healthcare said Saturday reports of any possible sale of the company were "totally unfounded."
It's official, piramal healthcare sold part of his company for $3.7 billion to abbot
Corporation Bank : Deposits grew 16.7% YoY and 1.7% QoQ to Rs985b says Motilal oswal
Hindustan Unilever Ltd ‘s 3QFY11 volumes grew 13%, the fourth consecutive quarter of double digit volume growth says Motilal Oswal
JAGRAN 3QFY11: Revenue increased 26.1% YoY and 3.3% QoQ to Rs 2.86b says Motilal oswal
Motilal Oswal expects NTPC to post net profit of Rs86.5b in FY11, Rs100.2b in FY12 and Rs119b in FY13
NTPC: Maintain Buy with a price target of Rs240 says Motilal Oswal
Bookmarks